1569071-58-4Relevant academic research and scientific papers
ORALLY ADMINISTRABLE VIRIDIOFUNGIN DERIVATIVE HAVING ANTI-HCV ACTIVITY
-
Paragraph 0644; 0645, (2015/07/02)
An object of the present invention is to provide a compound that is useful as an orally available anti-HCV agent. The present invention relates to a compound represented by formula (1) or a pharmaceutically acceptable salt thereof. This compound has an anti-HCV activity and is useful as a medicine.
The genetic incorporation of thirteen novel non-canonical amino acids
Tuley, Alfred,Wang, Yane-Shih,Fang, Xinqiang,Kurra, Yadagiri,Rezenom, Yohannes H.,Liu, Wenshe R.
supporting information, p. 2673 - 2675 (2014/03/21)
Thirteen novel non-canonical amino acids were synthesized and tested for suppression of an amber codon using a mutant pyrrolysyl-tRNA synthetase-tRNAPylCUA pair. Suppression was observed with varied efficiencies. One non-canonical amino acid in particular contains an azide that can be applied for site-selective protein labeling. The Royal Society of Chemistry 2014.
